SPONSOR
H. Lee Moffitt Cancer Center and Research Institute
Total Trials
11
Recruiting
11
Phases
Phase 2, Phase 1
Conditions studied: Breast CancerLeptomeningeal DiseaseDiffuse Large B Cell LymphomaAcute Lymphoblastic LeukemiaSmall Lymphocytic Lymphoma (SLL)Chronic Lymphocytic Leukemia (CLL)Metastatic Castration-resistant Prostate CancerRelapsed or Refractory Acute Myeloid Leukemia (AML)Metastatic Breast CancerMerkel Cell Carcinoma
H. Lee Moffitt Cancer Center and Research Institute is a clinical research sponsor with 11 registered studies on ClinicalTrials.gov, of which 11 are actively recruiting participants. Research covers conditions including Breast Cancer, Leptomeningeal Disease, Diffuse Large B Cell Lymphoma, Acute Lymphoblastic Leukemia.
The trial portfolio spans Phase 2, Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — H. Lee Moffitt Cancer Center and Research Institute
How many clinical trials has H. Lee Moffitt Cancer Center and Research Institute sponsored?
ClinicalMetric currently tracks 11 clinical trials sponsored by H. Lee Moffitt Cancer Center and Research Institute, of which 11 are actively recruiting participants. These trials cover conditions including Breast Cancer, Leptomeningeal Disease, Diffuse Large B Cell Lymphoma. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does H. Lee Moffitt Cancer Center and Research Institute research focus on?
H. Lee Moffitt Cancer Center and Research Institute clinical trials span Breast Cancer, Leptomeningeal Disease, Diffuse Large B Cell Lymphoma, Acute Lymphoblastic Leukemia, Small Lymphocytic Lymphoma (SLL), and additional conditions. The research pipeline includes Phase 2, Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a H. Lee Moffitt Cancer Center and Research Institute clinical trial?
To participate in a H. Lee Moffitt Cancer Center and Research Institute trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all H. Lee Moffitt Cancer Center and Research Institute trials with current recruitment status updated daily.
Clinical Trials by H. Lee Moffitt Cancer Center and Research Institute
NCT07694986 Phase 2
Recruiting
Trial of Therapies With IT cDC1s Combined w/ IT Trastuzamab for Her+ or IT Nivolumab for Her- BC LMD
Breast Cancer
NCT05757219 Phase 2
Recruiting
Itacitinib Pre-modulation in DLBCL Receiving CAR T Cell Therapy
Diffuse Large B Cell Lymphoma
NCT05581030 Phase 1
Recruiting
CalPeg for Newly Diagnosed Acute Lymphoblastic Leukemia (ALL)
Acute Lymphoblastic Leukemia
NCT07030400
Recruiting
Predictors of Health-Related QOL in Adults With CLL or Small Lymphocytic Lymphoma
Small Lymphocytic Lymphoma (SLL)
NCT07476001 Phase 2
Recruiting
Phase 2a Study of High-Dose Testosterone Followed by Radioligand Therapy in mCRPC
Metastatic Castration-resistant Prostate Cancer
NCT06660368 Phase 2
Recruiting
BCL2i CLAG-M in R/R Acute Myeloid Leukemia
Relapsed or Refractory Acute Myeloid Leukemia (AML)
NCT06409390 Phase 2
Recruiting
Sequential Therapies Modeled on Evolutionary Dynamics for Breast Cancer
Metastatic Breast Cancer
NCT04975152 Phase 1
Recruiting
Neoadjuvant Cemiplimab in Newly Diagnosed or Recurrent Stage I-II Merkel Cell Carcinoma and Locoregionally Advanced Cutaneous Squamous Cell Carcinoma
Merkel Cell Carcinoma
NCT06327685 Phase 1
Recruiting
Avapritinib With Decitabine in Patients With SM-AHN
Systemic Mastocytosis With an Associated Hematologic Neoplasm
NCT06745895
Recruiting
Multilevel Action Toward Colorectal Cancer and Hepatitis C Education and Screening
Colorectal Cancer Screening
NCT05301283 Phase 2
Recruiting
Habitat Escalated Adaptive Therapy (HEAT), With Neoadjuvant Radiation for Soft Tissue Sarcoma
High Grade Sarcoma
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology